Martin C. Muller

Mannheim, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia.

Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia.

Journal: Leukemia
Published: December 23, 2024

Glasgow coma scale score before prehospital tracheal intubation in trauma vs. nontrauma patients: A multicentre retrospective observational study.

Glasgow coma scale score before prehospital tracheal intubation in trauma vs. nontrauma patients: A multicentre retrospective observational study.

Journal: European journal of anaesthesiology
Published: December 20, 2024

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.

Journal: Leukemia
Published: March 05, 2022

SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment.

SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment.

Journal: Leukemia & lymphoma
Published: December 07, 2021

New Drug for Chronic Myeloid Leukemia Might Stimulate the Market.

New Drug for Chronic Myeloid Leukemia Might Stimulate the Market.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 02, 2020

Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.

Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.

Journal: The Journal of molecular diagnostics : JMD
Published: January 15, 2019

The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis.

The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis.

Journal: Haematologica
Published: November 26, 2018

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.

Journal: Blood
Published: February 25, 2018

Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.

Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.

Journal: Clinical lymphoma, myeloma & leukemia
Published: January 04, 2018

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.

Journal: The Lancet. Oncology
Published: November 15, 2017

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.

Journal: Leukemia
Published: November 08, 2017

High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.

High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 01, 2017
Showing 1-12 of 47

Last Updated: 09/26/2026